Loading...
Loading...
Browse all stories on DeepNewz
VisitWill CHIEF AI model receive FDA approval by end of 2025?
Yes • 50%
No • 50%
FDA official announcements or press releases
Harvard Scientists Develop CHIEF AI Model with 96% Accuracy for Diagnosing 19 Cancer Types
Oct 21, 2024, 05:05 AM
Harvard Medical School researchers have developed an AI model, CHIEF (Clinical Histopathology Imaging Evaluation Foundation), capable of diagnosing cancer with up to 96% accuracy across 19 cancer types, including lung and prostate cancer. The ChatGPT-like AI can predict tumor molecular profiles from images, guide treatment choices, and predict patient outcomes. CHIEF was trained on 15 million unlabeled images, enabling it to identify features linked to various cancer types. This revolutionary development represents a significant leap forward in cancer diagnosis and treatment.
View original story